Onderzoeker
Rob van der Kant
- Disciplines:Laboratoriumgeneeskunde, Palliatieve zorg en zorg rond het levenseinde, Regeneratieve geneeskunde, Andere basiswetenschappen, Andere gezondheidswetenschappen, Verpleegkunde, Andere paramedische wetenschappen, Andere translationele wetenschappen, Andere medische en gezondheidswetenschappen
Affiliaties
- Switch Laboratorium (VIB-KU Leuven) (Afdeling)
Lid
Vanaf1 nov 2013 → Heden
Publicaties
1 - 10 van 22
- Reverse engineering synthetic antiviral amyloids (vol 11, 2832, 2020)(2023)
Auteurs: Emiel Michiels, Rodrigo Gallardo, Laleh Khodaparast, Ladan Khodaparast, Rob van der Kant, Bert Houben, Nikolaos Louros, Suzanne Kaptein, Guy Bormans, Johan Neyts, et al.
- Sodium glutamate and glutamic acid decarboxylase as alternative for classical chemical leavening in wheat (pan)cake batter systems(2023)
Auteurs: Thibault Godefroidt, Rob van der Kant, Elien Lemmens, Lomme Deleu, Kurt Gebruers, Joost Schymkowitz, Frederic Rousseau, Jan Delcour
- Reduced Levels of Misfolded and Aggregated Mutant p53 by Proteostatic Activation(2023)
Auteurs: Filip Claes, Rob van der Kant, Mark Fiers, Stein Aerts, Frederic Rousseau, Joost Schymkowitz, Frederik De Smet
- Exploiting the intrinsic misfolding propensity of the KRAS oncoprotein(2023)
Auteurs: Kobe Janssen, Filip Claes, Bert Houben, Mieke Nys, Laleh Khodaparast, Ladan Khodaparast, Nikolaos Louros, Rob van der Kant, Katerina Konstantoulea, Joost Schymkowitz, et al.
- Thermodynamic analysis of amyloid fibril structures reveals a common framework for stability in amyloid polymorphs(2022)
Auteurs: Rob van der Kant, Nikolaos Louros, Joost Schymkowitz, Frederic Rousseau
Pagina's: 1178 - + - The effect of mutation on an aggregation-prone protein: An in vivo, in vitro, and in silico analysis(2022)
Auteurs: Rob van der Kant, Frederic Rousseau, Joost Schymkowitz
- StAmP-DB: a platform for structures of polymorphic amyloid fibril cores(2022)
Auteurs: Nikolaos Louros, Rob van der Kant, Joost Schymkowitz, Frederic Rousseau
Pagina's: 2636 - 2638 - Defective Sec61α1 underlies a novel cause of autosomal dominant severe congenital neutropenia(2020)
Auteurs: Erika Van Nieuwenhove, Julika Neumann, Elien Smeets, Emanuela Pasciuto, Vasiliki Lagou, Laura Seldeslachts, Bert Malengier-Devlies, Mieke Metzemaekers, Rob van der Kant, Joost Schymkowitz, et al.
Pagina's: 1180 - 1193 - Reverse engineering synthetic antiviral amyloids(2020)
Auteurs: Emiel Michiels, Rodrigo Gallardo, Laleh Khodaparast, Ladan Khodaparast, Rob van der Kant, Bert Houben, Nikolaos Louros, Suzanne Kaptein, Guy Bormans, Johan Neyts, et al.
- Autonomous aggregation suppression by acidic residues explains why chaperones favour basic residues(2020)
Auteurs: Bert Houben, Emiel Michiels, Katerina Konstantoulea, Nikolaos Louros, Joffré Verniers, Rob van der Kant, Matthias De Vleeschouwer, Rodrigo Gallardo, Joost Schymkowitz, Frederic Rousseau
Patenten
1 - 2 van 2
- Carbon dioxide generation (Inventor)
- Carbon dioxide generation (Inventor)